Asian Tribune Your Multilingual Newspaper covering World and local news News
Drug firm Mankind Pharma on Thursday said it has received licence from the Defence Research and Development Organisation (DRDO) to manufacture and market oral 2-deoxy-D-glucose (2-DG), used for the treatment of COVID-19. 2-DG was developed by the Defence Research and Development Establishment (DRDE), Gwalior. The clinical trials were conducted by …
Read More »Mankind Pharma gets DRDO nod to manufacture, market COVID drug 2-DG, Health News, ET HealthWorld
